Neurotrophin stimulation of human melanoma cell invasion: Selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations

Cancer Research

Volumn 56, Issue 12, 1996, Pages 2856-2863

  Marchetti, Dario ^a,c   McQuillan, David J ^b   Spohn, William C ^a   Carson, Dan D ^a   Nicolson, Garth L ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARAN SULFATE; HEPARANASE; NEUROTROPHIN;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; MELANOMA; METASTASIS POTENTIAL; PRIORITY JOURNAL;

BASE SEQUENCE; BRAIN NEOPLASMS; BRAIN-DERIVED NEUROTROPHIC FACTOR; COLLAGEN; DRUG COMBINATIONS; ELECTROPHORESIS, AGAR GEL; GLUCURONIDASE; GLYCOSAMINOGLYCANS; GLYCOSIDE HYDROLASES; HEPARITIN SULFATE; HUMANS; LAMININ; MELANOMA; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; NEOPLASM INVASIVENESS; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEUROTROPHIN 3; OLIGONUCLEOTIDES, ANTISENSE; PROTEOGLYCANS; RECEPTOR, NERVE GROWTH FACTOR; RECEPTORS, NERVE GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 0029929228     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Nicolson, G. L. Metastatic tumor cell interactions with endothelium basement membrane and tissue. Curr. Opin. Cell Biol., 1: 1009-1019, 1989.
2. Yurchenco, P. D., Tsilibary, E. C , Charonis, A. S., and Furthmayr, H. Models for self-assembly of basement membrane. J. Histochem Cytochem., 34: 93-102, 1986.
3. Nakajima, M., Inmura, T., and Nicolson, G. L. Heparanase and tumor metastasis J, Cell. Biochem., 36, 157-167, 1986.
4. Liotta, L. A., Steeg, P. S , and Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327-336, 1991.
5. Nicolson, G. L., Nakajima, M., Hermann, J. L., Menter, D. G., Cavanaugh, P., Park, J. S., and Marchetti, D. Malignant melanoma metastasis to brain: role of degradative enzymes and responses to paracrine growth factors. J. Neuro-Oncol., 18: 139-149, 1994.
6. Nicolson, G. L., Menter, D G , Herrmann, J L., Cavanaugh, P , Jia, L., Hamada, J , Yun, Z , and Marchetti, D Tumor metastasis to brain: role of endothelial cells, neurotrophin, and paracrine growth factors. Crit. Rev. Oncog, 5 451-471, 1994.
7. Marchetti, D., Menter, D., Jin, L., Nakajima, M., and Nicolson, G. L. Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production Int. J. Cancer, 55, 692-699, 1993.
8. Herrmann, J. H., Menter, D. G , Hamada, J., Marchetti, D., Nakajima, M , and Nicolson, G. L. Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trkA. Mol. Biol. Cell. 4: 1205-1216, 1993.
9. Chao, M. V. Growth factor signaling: where is the specificity? Cell, 68 995-997, 1992.
10. Bothwell, M. Tissue localization of nerve growth factor and nerve growth factor receptors. Curr. Top. Microbiol. Immunol., 165: 55-70, 1991
11. Barbacid, M. Nerve growth factor: a tale of two receptors. Oncogene, 8, 2033-2044, 1993.
12. Lamballe, F., Klein, R , and Barbacid, M. TrkC, a new member of the TRK family of tyrosine protein kinase, is a receptor for neurotrophin-3. Cell, 66: 967-979, 1991.
13. Thoenen, H , Bandtlow, C., and Heuman, R. The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rev. Physiol. Biochem Pharmacol., 109, 145-178, 1987
14. Marchetti, D , McCutcheon, I., Ross, H. I , and Nicolson, G. L. Inverse expression of neurotrophin receptor and neurotrophins at the invasion front of brain-metastatic human melanoma tissues Int. J. Oncol., 7: 87-94, 1995.
15. Dietrich, C P., Sampio, L O., and Toledo, O. M. Characteristic distribution of sulfated mucopolysaccharides in different tissues and in their respective mitochondria. Biochem Biophys Res Commun., 71: 1-10, 1976.
16. Hedman, K., Kurkinen, M., Alitalo, K., Vaheri, A., Johansson, S., and Hook, M Isolation of the pericellular matrix of human fibroblast cultures. J. Cell Biol., 81: 83-91, 1979.
17. Murdoch, A. D., Liu, B , Schwarting, R , Tuan, R. S., and Iozzo, R. V. Widespread expression of perlecan proteoglycac in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J. Histochem. Cytochem., 42: 239-249, 1994.
18. Cohen, I. R., Murdoch, A. D., Naso, M F , Marchetti, D., Berd, D , and Iozzo, R V. Abnormal expression of perlecan in metastatic melanoma. Cancer Res , 54: 5771-5774, 1994.
19. Iozzo, R. V , Cohen, I. R., Grassel, S , and Murdoch, A D The biology of perlecan: the multifaceted heparan sulfate proteoglycan of basement membranes and pericellular matrices. Biochem. J., 302 625-639, 1994.
20. Iozzo, R V Proteoglycans: structure, function and role in neoplasia Lab Invest., 53, 373-396, 1985.
21. Ishikawa, M., Fernandez, B , and Kerbel, R. S Highly pigmented human melanoma variant which metastasizes widely in nude mice, including to skin and brain Cancer Res , 48: 4897-4903, 1988.
22. Way, D. L , Grosso, P S., Davis, J R., Surwit, E. A , and Christian, C D Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture. In Vitro, 19: 147-158, 1983.
23. Ronde, L H., and Carson, D. D. Heparin-like glycosaminoglycans participate in binding of a human trophoblastic cell line (JAR) to a human uterine epithelial cell line (RL95). J. Cell. Physiol., 155, 185-196, 1993
24. Nakajima, M , Irimura, T., and Nicolson, G L. A solid phase substrate of heparanase: its application to assay of human melanoma for heparan sulfate degradative activity. Anal. Biochem., 157, 162-171, 1986
25. Escandon, E., Burton, L E., Szonyi, E , and Nikolics, K Characterization of neurotrophin receptors by affinity crosslinking. J. Neurosci Res., 34: 601-613, 1993.
26. Marchetti, D , and McManaman, J L. Characterization of nerve growth factor binding to embryonic rat spinal cord neurons. J. Neurosci Res., 27: 211-218, 1990.
27. Johnson, D., Lanahan, A., Buck, C. R., Sehgal, A., Morgan, C., Mercer, E. Bothwell, M , and Chao, M. Expression and structure of the human NGF receptor. Cell, 47 545-554, 1986.
28. Sariola, H., Saarma, M , Sainio, K., Arumaae, U., Palgi, J , Vaahtokari, A , Thesleff, I., and Karavanov, A. Dependence of kidney morphogenesis on the expression of nerve growth factor receptor. Science (Washington DC), 254: 571-573, 1991
29. Carlson, D. M Structures and immunochemical properties of oligosaccharides isolated from pig submaxillary mucins. J. Biol. Chem., 243, 616-626, 1968.
30. Wasteson, A. A method for the determination of the molecular weight and molecular weight distribution of chondroitin sulfate. J. Chromatogr., 59, 87-97, 1971.
31. McQuillan, D. J., Findlay, D M., Hocking, A. M., Yanagishita, M., Midura, R J., and Hascall, V. C. Proteglycans synthesized by an osteoblast-like cell line (UMR 106-01). Biochem J., 277: 199-206, 1991.
32. Shively, J. E., and Conrad, H. E. Formation of anhydrous sugars in the chemical depolymerization of heparin. Biochemistry. 15: 3932-3942, 1976.
33. Ibanez, C F , Efbendal, T , Barbany, G., Murray-Rust, J., Blundell, T. L., and Persson, H. Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product. Cell, 69: 329-341, 1992
34. Fabricant, R N., De Larco, J. E., and Todaro, G. L. Nerve growth factor receptors on human melanoma cells in culture. Proc. Natl Acad Sci USA, 74: 565-569, 1977.
35. Kaplan, D R , Hempstead, B L., Martin, Z. D., Chao, M. V., and Parada, L. F The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science (Washington DC), 252: 554-558, 1991.
36. Nakajima, M., Irimura, T , Di Ferrante, D , Di Ferrante, N., and Nicolson, G. L. Heparan sulfate degradation, relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science (Washington DC), 220: 611-613, 1983.
37. Nakajima, M , Irimura, T , Di Ferrante, N , and Nicolson, G. L. Metastatic melanoma heparanase. J Biol Chem., 259: 2283-2290, 1984
38. Sjoberg, I., and Fransson, L-A. Structural studies on heparan sulphate from human lung fibroblasis Biochem J , 191: 103-110, 1980
39. Ernst, S., Langer, R., Cooney, C L., and Sasisekharan, R. Enzymatic degradation of glycosaminoglycans Crit. Rev. Biochem. Mol. Biol., 30: 387-444, 1995.
40. Gallagher, J T., Turnbull, J. E., and Lyon, M. Heparan sulphate proteoglycans Biochem. Soc. Trans. 18: 207-209, 1990.
41. Fransson, L A , Havsmark, B , and Sheehan, J. K. Self-association of heparan sulfate. Demonstration of binding by affinity chromatography of free chains on heparan sulfate-substituted agarose gels. J. Biol Chem., 256: 13039-13043, 1981.
42. Sloane, B F., Dunn, J. R., and Honn, K V. Calcium spike electrogenesis and other electrical activity in continuously cultured small cell carcinoma of the lung Science (Washington DC), 2/2. 1151-1153, 1981
43. Sloane, B F., Honn, K V , Sadler, J G., Turner, W. A., Kimpson, J. J , and Taylor, J. D. Cathepsin B activity in B16 melanoma cells, a possible marker for metastatic potential. Cancer Res., 42: 980-986, 1982.
44. Nakajima, M., De Chavigny, A., Johnson, C. E., Hamada, J , Stein, C. A., and Nicolson, G L. Suramin J Biol. Chem , 266 9661-9666, 1991.
45. Menter, D G , Herrmann, J. L., and Nicolson, G. L The role of trophic factors and autocrine/paracrine growth factors in brain metastasis. Clin Exp. Metastasis, 13: 67-88, 1995.
46. Patel, J. K , Didolkar, M S , Pickren, J W., and Moore, R. H. Metastatic pattern of malignant melanoma, a study of 216 autopsy cases. Am. J. Surg , 135, 807-810, 1978.
47. Herlyn, M. Human melanoma: development and progression. Cancer Metastasis Rev., 9: 101-112, 1990
48. Jin, L., Nakajima, M , and Nicolson, G. L Immunochemical localization of heparanase in mouse and human melanomas Int J. Cancer. 45 1088-1095, 1990
49. Whittemore, S. C., and Seiger, A. The expression, localization and functional significance of β-nerve growth factor in the central nervous system. Neurosci Rev . 12 439-464, 1987.
50. Hefti, F. Neurotrophic factor therapy for nervous system degenerative diseases J. Neurobiol, 25: 1418-1435, 1994
51. Menter, D. G., Herrmann, J L., Marchetti, D . and Nicolson, G L. Involvement of neurotrophins and growth factors in brain metastasis formation Invasion Metastasis, 14: 372-384, 1995